Entering text into the input field will update the search result below

Schein takes issue with anti-trust allegations

Feb. 13, 2018 9:00 AM ETHenry Schein, Inc. (HSIC) StockBy: Douglas W. House, SA News Editor1 Comment
  • Medical products distributor Henry Schein (NASDAQ:HSIC) disagrees with allegations from the U.S. Federal Trade Commission that it engaged in anti-competitive behavior related to discounts to buying groups for dental supplies.
  • In a statement, the company says, "Based on the FTC's press release, the Company is being accused of participating in a conspiracy to refuse to provide discounts to, or compete for, the business of buying groups. Contrary to the FTC's allegations, the Company was a leader in supplying buying groups, has consistently done business with buying groups, has a dedicated team to serve buying groups, and never entered into an agreement with others to refuse to do business with buying groups. Based on the FTC's original definition of buying groups, the Company does business with more than 100 buying groups. Even under a narrower definition recently advanced by the FTC, the Company has done business, and continues to do business, with the very groups it is now accused of boycotting. The Company believes that the allegations as described in the press release are meritless and intends to defend itself vigorously. The Company does not anticipate that this matter will have a material adverse effect on our financial condition or results of operations."
  • Shares are down 7% premarket on light volume.
  • Previously: FTC alleges dental supply companies conspired to refuse discounts (Feb. 12)

Recommended For You

About HSIC Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
HSIC--
Henry Schein, Inc.